State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Dept. of Oral Medicine of West China Hospital of Stomatology, Sichuan University, No. 14, Sec.3, Renminnan Road, Chengdu, Sichuan, 610041, China.
Department of Periodontics and Oral Medicine, University of Michigan School of Dentistry Comprehensive Cancer Center, 1600 Huron Parkway 2355, Ann Arbor, MI, 48109, USA.
Mol Cancer. 2018 Jan 24;17(1):14. doi: 10.1186/s12943-018-0763-7.
Head and neck cancer (HNC) ranks as the 6th most common malignancy across the world. Metastasis is a hallmark of cancer, primarily contributing to the relapse and poor prognosis of HNC. Recently, long noncoding RNAs (lncRNAs), previously considered as non-functional, are increasingly appreciated by scholars to play crucial roles in mediating HNC metastasis. LncRNAs, which are located in the nucleus and cytoplasm, mainly exert their function via epigenetic modification, transcriptional control and translational regulation. As several lncRNAs are presently demonstrated to participate in HNC metastasis, we make a summary of the functions and mechanisms regarding these lncRNAs. As shown in the literature, most lncRNAs appear to promote the metastasis of HNC. Hence, we primarily discuss the lncRNAs involved in enhancing metastasis. Additionally, more studies are needed to understand those lncRNAs without clear mechanisms. Furthermore, we introduced the upstream regulator for the aberrant expression of lncRNAs in HNC. Finally, we concisely addressed future research prospects of lncRNAs, particularly the interplay between lncRNAs and tumor immunity as well as lncRNA-targeted therapeutic techniques, and we introduced clustered regularly interspaced short palindromic repeats (CRISPR)-Display as a possibly transformative tool to study lncRNAs. Although lncRNA research is still in the initial stage, it holds great promise to be applied as a prognosticator of HNC and a therapeutic target to inhibit HNC metastasis, which could significantly enhance the outcome of HNC patients.
头颈部癌症(HNC)是全球第 6 常见的恶性肿瘤。转移是癌症的一个标志,主要导致 HNC 的复发和预后不良。最近,长链非编码 RNA(lncRNA),以前被认为是非功能性的,越来越受到学者的重视,在介导 HNC 转移中发挥着关键作用。lncRNA 位于细胞核和细胞质中,主要通过表观遗传修饰、转录调控和翻译调控发挥作用。由于目前有几种 lncRNA 被证明参与了 HNC 的转移,我们总结了这些 lncRNA 的功能和机制。文献表明,大多数 lncRNA 似乎促进了 HNC 的转移。因此,我们主要讨论了那些参与增强转移的 lncRNA。此外,还需要更多的研究来了解那些机制尚不明确的 lncRNA。此外,我们介绍了 HNC 中 lncRNA 异常表达的上游调节剂。最后,我们简要地讨论了 lncRNA 的未来研究前景,特别是 lncRNA 与肿瘤免疫之间的相互作用以及 lncRNA 靶向治疗技术,并介绍了 CRISPR-Display 作为一种可能具有变革性的研究 lncRNA 的工具。尽管 lncRNA 的研究仍处于起步阶段,但它有望成为 HNC 的预后标志物和抑制 HNC 转移的治疗靶点,这将显著改善 HNC 患者的预后。